Given these results in the hematopoietic system, future studies should consider whether effects on IGF signaling might contribute to other aspects of the syndrome, such as the almost universal metabolic changes that make many individuals with trisomy 21 more prone to obesity or diabetes. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.